Results 281 to 290 of about 318,338 (358)

Consortium CPGs

open access: yes
Consortium CPGs - clinical guidelines on sarcoma patient ...
openaire   +1 more source

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges

open access: yesBritish Journal of Pharmacology, EarlyView.
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu   +6 more
wiley   +1 more source

Hepatitis B vaccination with HepB-CpG in people living with HIV: a narrative review

open access: diamond
Kelvin McKoy   +3 more
openalex   +1 more source

Advancements in Inorganic Chiral Nanomaterials for Anti‐Tumor Immunotherapy

open access: yesCancer Science, EarlyView.
Schematic illustration of how inorganic chiral nanomaterials enhance immune activation to promote tumor cell elimination through targeted delivery, immunogenic cell death, and immune microenvironment modulation. ABSTRACT While the past decade has witnessed unprecedented technological advancements, cancer remains a major health threat, with conventional
Siyu Chen   +9 more
wiley   +1 more source

Super‐Enhancer Formation in Scirrhous Gastric CAFs, and the Presence of a Stromal Field in Non‐Cancerous Tissues

open access: yesCancer Science, EarlyView.
While CAFs are produced as a result of education by cancer cells in non‐scirrhous gastric cancer, normal fibroblasts of scirrhous gastric cancer patients are already pre‐conditioned, forming a stromal field for scirrhous gastric cancer. ABSTRACT Scirrhous gastric cancer has aggressive clinical courses and is characterized by dominating cancer ...
Yoshimi Yasukawa   +12 more
wiley   +1 more source

Stoking an anti-liver cancer immune response with cryoablation plus an intratumoral TLR9 agonist and dual checkpoint inhibitors. [PDF]

open access: yesCancer Immunol Immunother
Yang Y   +11 more
europepmc   +1 more source

Subunit vaccination using Atomic Layering Thermostable Antigen and Adjuvant (ALTA<sup>®</sup>) platform elicits enhanced humoral and cellular immune responses. [PDF]

open access: yesFront Immunol
Ivanova DL   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy